Evidence-Based Complementary and Alternative Medicine

Herbal Medicines and Natural Products for Genitourinary Cancer Treatment


Publishing date
01 May 2022
Status
Closed
Submission deadline
31 Dec 2021

Lead Editor

1University of the Punjab, Lahore, Pakistan

2Shandong University, Jinan, China

3University of Science and Technology Bannu, Banu, Pakistan

This issue is now closed for submissions.
More articles will be published in the near future.

Herbal Medicines and Natural Products for Genitourinary Cancer Treatment

This issue is now closed for submissions.
More articles will be published in the near future.

Description

Genitourinary (GU) cancers account for 30% of all cancers in men. These cancers are one of the most common cancer diseases worldwide. Prostate cancer accounts for 20% of all cancers. In general, bladder and kidney cancers are common cancers in men. Meanwhile, testicular cancer is the most common cancer in young men. The high incidence of GU cancer has generated a great interest in the pharmacotherapy of GU cancer.

Treatment of genitourinary cancer is primarily based on combinative therapeutic approaches to overcome the limitations upon single agent-based therapeutic strategies. Nutraceuticals and complementary treatments are gaining popularity as they can treat various cancers due to numerous useful effects. There has been strong evidence that herbal medicines and natural products are vital for the management of genitourinary cancer in terms of improving treatment outcomes. Moreover, these products are able to reduce the severe cytotoxic side effects of chemotherapy, which is one of the major limitations of all cancer therapies (including GU). Further research in this field will help improve the availability of therapeutic approaches for cancer patients. Further studies are needed to understand how we can strengthen antitumoral responses, ameliorate disease prognosis and patient outcomes.

The aim of this Special Issue is to bring together original research and review articles discussing herbal medicine and natural products for the management of genitourinary cancers. Submissions should also discuss the use of these products for genitourinary cancer treatment.

Potential topics include but are not limited to the following:

  • Herbal medicines and natural products for prostate cancer treatment
  • Herbal medicines and natural products as chemotherapeutic agents in bladder cancer
  • Herbal medicines and natural products in testicular cancer
  • Herbal medicines and natural products in penile cancer
  • Herbal medicines and natural products in adrenocarcinoma
  • Natural products and conventional therapeutic approaches as anticancer agents for genitourinary cancer
  • Preclinical and clinical studies discussing the use of herbal medicines and natural products for genitourinary cancer treatment
  • Herbal medicine and natural compounds as cytoprotective agents to reduce toxicity in genitourinary cancer
  • Herbal medicine and natural products effects on immunity during genitourinary cancer therapy
  • Anti-genitourinary cancer mechanisms of herbal medicines and natural products

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 1821719
  • - Research Article

Efficacy of Modified Qingre Jiedu Decoction Combined with Three-Dimensional Conformal Radiotherapy in Treating Moderate to Advanced Ovarian Carcinoma and Its Effect on Levels of Serum Carcinoembryonic Antigen and Carbohydrate Antigen 125

Shufen Ai | Jin Xie
  • Special Issue
  • - Volume 2022
  • - Article ID 6211543
  • - Research Article

Application Effect of Bladder Function Training Combined with Kangaiping Pills on Permanent Bladder Stoma after Radical Prostatectomy

Kefu Sha | Yue Zhao | ... | Tiejun Liu
  • Special Issue
  • - Volume 2022
  • - Article ID 1091042
  • - Research Article

PTPN18 Stimulates the Development of Ovarian Cancer by Activating the PI3K/AKT Signaling

Nan Mao | Hu Li | ... | Guansheng He
  • Special Issue
  • - Volume 2022
  • - Article ID 2655858
  • - Research Article

Effect of Combined Spinal-Epidural Anesthesia and Total Intravenous Anesthesia on Hemodynamics and Pregnancy Outcomes of Severe Preeclampsia Pregnant Patients Undergoing Cesarean Section

Guangrong Wang | Pengyu Zhang | ... | Hua Li
  • Special Issue
  • - Volume 2022
  • - Article ID 5215915
  • - Research Article

Irisin Activates M1 Macrophage and Suppresses Th2-Type Immune Response in Rats with Pelvic Inflammatory Disease

Zhenge Zhang | Chongyuan Zhang | Shuirong Zhang
  • Special Issue
  • - Volume 2022
  • - Article ID 8232851
  • - Research Article

Root Extract of a Micropropagated Prunus africana Medicinal Plant Induced Apoptosis in Human Prostate Cancer Cells (PC-3) via Caspase-3 Activation

Richard Komakech | Nam-Hui Yim | ... | Youngmin Kang
  • Special Issue
  • - Volume 2022
  • - Article ID 7178711
  • - Research Article

The Application Effect of Traditional Chinese Medicine Nursing on General Anesthesia Combined with Epidural Anesthesia and Electric Resection for the Treatment of Bladder Cancer and Its Influence on Tumor Markers

Yan Wu | Zhenna Zhang | ... | Xuehai Ding
  • Special Issue
  • - Volume 2022
  • - Article ID 7728739
  • - Research Article

The Clinical Efficacy of Chemotherapy Combined with Traditional Chinese Medicine in the Treatment of Cervical Cancer and Its Influence on Cellular Immunity, Serum CEA, and TNF-α

Qiannan Zhao | Juanjuan Liu | ... | Xiufang Jiang
  • Special Issue
  • - Volume 2021
  • - Article ID 4355805
  • - Research Article

Diagnosis Value of Colposcope Combined with Serum Squamous Cell Carcinoma Antigen, Carbohydrate Antigen 125, and Carcinoembryonic Antigen for Moderate to Advanced Cervical Cancer Patients Treated with Modified Fuzheng Peiyuan Decoction

Huijuan Meng | Yulan Zhang | Youguo Chen
  • Special Issue
  • - Volume 2021
  • - Article ID 5481271
  • - Research Article

Ginkgolic Acid (GA) Inhibits the Growth of OCa by Inhibiting lncRNA MALAT1/JAK2 Axis

Zhiyi Fei | Yi Yu | ... | Fang Luo
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate27%
Submission to final decision75 days
Acceptance to publication21 days
CiteScore3.200
Journal Citation Indicator0.740
Impact Factor2.650
 Submit

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.